Abbott Laboratories (ABT)

[DewDiligence]

FDA clears ABT's standalone glucose reader from FreestyleLibre:

https://finance.yahoo.com/news/fda-clears-reader-abbotts-freestyle-130000671.html

Abbott today announced that the U.S. Food and Drug Administration (FDA) has cleared a reader for its FreeStyle Libre 3 integrated continuous glucose monitoring (iCGM) system, which features the world's smallest, thinnest and most discreet glucose sensor. With the FDA's clearance of a standalone reader, Abbott is working to get the FreeStyle Libre 3 system added to Medicare's list of covered systems as soon as possible.